Fundraising FoxFounders Fund — 2016 Investments
10 investments dated 2016 · listed companies and verified rows first · show all
AbbVie develops and sells biopharmaceutical therapies across immunology, neuroscience, oncology, and aesthetics, addressing autoimmune diseases, neurologic conditions, blood cancers, and cosmetic applications through products like Skyrizi, Rinvoq, Humira, Vraylar, Imbruvica, and Botox.
BiotechNorth Chicago, US
Thomas A. Hurwich(Executive Officer)Timothy J. Richmond(Executive Officer)Henry Gosebruch(Executive Officer)inAzita Saleki-Gerhardt(Executive Officer)inMichael E. Severino(Executive Officer)William Chase(Executive Officer)
Co-investorsArtis Ventures
Blend offers a Consumer Banking Suite, a digital platform for banks and financial institutions to originate and process consumer lending and deposit products.
Enterprise SoftwareFintechPropTechSaaSSan Francisco, US
Nima Ghamsari(Co-founder & Head of Blend)inErin Collard(Co-Founder)inEugene Marinelli(Co-Founder)inRosco Hill(Co-Founder)inJason Ream(Head of Finance and Administration (CFO))in
BoardTimothy J. Mayopoulos(Board Member)
Co-investors8VCBallistic VenturesCanapi VenturesCoatue ManagementConversion CapitalEmergence Capital Partners+15 more
8i develops virtual and augmented reality technologies for human connection and immersive experiences, serving audiences across entertainment, education, training, and professional settings.
AI & Machine LearningDeep TechMedia & EntertainmentLos Angeles, US
Lincoln Gasking(Executive Officer, Director)Hayes Mackaman(CEO)
BoardJames D Robinson(Director)inScott Levine(Director)
Board seatScott Nolan· per SEC Form D · $22.5M raise · filed Nov 2016
Co-investorsAdvancit CapitalDolby Family VenturesRight Click CapitalRRE VenturesSamsung NextWestern Technology Investment
LTSE operates the Long-Term Stock Exchange, an SEC-regulated national securities exchange built to connect companies with long-term investors, and also offers cap table management software for startups.
Enterprise SoftwareFintechSaaSSan Francisco, US
Eric Ries(Founder)inJohn Bautista(Founder)inNatalie RisoinMaliz BeamsinZoran Perkov(Founder)Mawulom Nenonene(People)
Board seatBrian Singerman· per SEC Form D
Co-investors500 GlobalAlumni VenturesAndreessen HorowitzCollaborative FundFloodgateGaingels+15 more
__Twitter.png)
Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Paul John Dabrowski(Executive Officer, Director)Michael Jakub Dabrowski(Executive Officer, Director)Craig Christianson(CEO)inAlex Pesch(Founder)Michael Dabrowski(Founder)Paul Dabrowski(Founder)
Board seatScott Nolan· per SEC Form D
Co-investorsAAF Management Ltd.AME Cloud VenturesDeclaration PartnersKhosla VenturesMenlo VenturesOpen Field Capital+11 more
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
Sajith Wickramasekara(CEO)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)Cory Liin
Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+31 more
Brave makes a privacy-focused web browser built on the open-source Chromium core that blocks third-party ads and trackers by default, along with an independent search engine, a device-wide VPN, and a built-in AI assistant.
AI & Machine LearningConsumerCybersecurity
Brendan Eich(Founder)inBrian Bondy(Founder)in
Co-investorsAbstract VenturesCoinbase VenturesDigital Currency GroupFoundation CapitalHemisphere Ventures LLCIncrypt Blockchain+12 more
Moffett Field, US
ROBERT RICHARDS(Executive Officer, Director)NAVEEN JAIN(Director)inBARNEY PELL(Director)inDAVEN MAHARAJ(Executive Officer)ANDREW ALDRIN(Executive Officer)in
Co-investorsCollaborative Fund
San Francisco, US
Tim Junio(Executive Officer)Matthew Kraning(Executive Officer, Director)Joseph Meyerowitz(Executive Officer, Director)Shaun Maguire(Director)
Co-investorsIVP (Institutional Venture Partners)New Enterprise Associates (NEA)Susa Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.